The effect of erythropoietin on interleukin-1β mediated increase in nitric oxide synthesis in vascular smooth muscle cells

Journal of Hypertension

Volumn 17, Issue 9, 1999, Pages 1249-1256

  Akimoto, Tetsu ^a   Kusano, Eiji ^a   Muto, Shigeaki ^a   Fujita, Nobuya ^a   Okada, Koji ^a   Saito, Toshikazu ^a   Komatsu, Norio ^a   Ono, Shuichi ^a   Ebata, Satoru ^a   Ando, Yasuhiro ^a   Homma, Sumiko ^a   Asano, Yasushi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Erythropoietin; Erythropoietin receptor; Interleukin 1 ; Nitric oxide; Nitric oxide synthase; Phospholipase C 1; Protein kinase C; Vascular smooth muscle cells

Indexed keywords

CALPHOSTIN C; ERYTHROPOIETIN RECEPTOR; INTERLEUKIN 1BETA; MESSENGER RNA; MYELIN BASIC PROTEIN; NITRIC OXIDE; NITRITE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; RECOMBINANT ERYTHROPOIETIN; STAUROSPORINE;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVATION; IMMUNOPRECIPITATION; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

EID: 0032759327     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917090-00003     Document Type: Article

References (46)

1. 1 Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43:109-142.
2. 2 Radomski MW, Palmer RMJ, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 1987; 92:181-187.
3. 3 Spessert R, Hill G, Vollrath L. In rat pinealocytes the cyclic GMP response to NO is regulated by Ca2+ and protein kinase C. Brain Res 1995; 694:207-212.
4. 4 Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995; 377:239-242.
5. 5 Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing favtor. Nature 1987; 327:524-526.
6. 6 Ignarro LJ, Bug GM, Wood KS, Byrns RE. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84:9265-9269.
7. 7 Xie OW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992; 256:225-228.
8. 8 Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH. Cloned and expressed macrophage nitric oxide synthase contrasts with brain enzyme. Proc Natl Acd Sci USA 1992; 89:6711-6715.
9. 9 Beasley D, Cohen RA, Levinsky NG. Interleukin-1 inhibits contraction of vascular smooth muscle. J Clin Invest 1989; 83:331-335.
10. 10 Beasley D, Schwarz JH, Brenner BM. Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J Clin Invest 1991; 87:602-608.
11. 11 Krantz SB. Erythropoietin. Blood 1991; 77:419-434.
12. 12 Anagnostou A, Liu Z, Steiner M, Chin K, Lee ES, Kesseimian N, et al. Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA 1994; 91:3974-3978.
13. 13 Ammarguellat F, Gogusev J, Drueke TB. Direct effect of erythropoietin on vascular smooth-muscle cell via a putative erythropoietin receptor. Nephrol Dial Transplant 1996; 11:687-692.
14. 14 Heidenrieich S, Rahn KH, Zideck W. Direct vasopressor effect of recombinant human erythropoitin on renal resistance vessels. Kidney Int 1991; 39:259-265.
15. 15 Dusanter-Fourt I, Casadevall N, Lacombe C, Muller O, Billat C, Fischer S, et al. Erythropoietin induces the tyrosine phosphorylation of its own receptor in human erythropoietin responsive cells. J Biol Chem 1992; 267:10670-10675.
16. 16 Damen JE, Ling L, Culter R, Krystal G. Erythropoietin stimulates the tyrosine phosphorylation of Shc and its association with Grb2 and 145-kd tyrosine phophorylated protein. Blood 1993; 81:3204-3210.
17. 17 Spivak JL, Fisher J, Isaacs MA, Hankins WD. Protein kinases and phosphatase are involved in erythropoietin-mediated signal transduction. Exp Hematol 1992; 20:500-504.
18. 18 Miller BA, Cheung JY. Mechanism of erythropoietin signal transduction: involvement of calcium channels. Proc Soc Exp Biol Med 1994; 206:263-267.
19. 19 Ren HY, Komatsu N, Shimizu R, Okada K, Miura Y. Erythropoietin induces tyrosine phosphorylation and activation of phophlipase C-γ1 in human erythropoietin-dependent cell line. J Biol Chem 1994; 269:19633-19638.
20. 20 Bailey SC, Spangler R, Sytkowski AJ. Erythropoietin induces cytosolic protein phosphorylation and dephosphorylation in erythroid cells. J Biol Chem 1991; 266:24121-24125.
21. 21 Wald MR, Borda ES, Sterin BL. Mitogenic effect of erythropoietin on neonatal rat cardiomyocytes signal transduction pathways. J Cell Physiol 1996; 167:461-468.
22. F is necessary for erythropoietin's up-regulation of c-myc and for factor-dependent DNA synthesis. J Biol Chem 1996; 271:27025-27030.
23. 23 Kusano E, Akimoto T, Inoue M, Masunaga Y, Umino T, Ono S, et al. Human recombinant erythropoietin inhibits interleukin-1β stimulated nitric oxide and cyclic monophosphate production in cultured rat vascular smooth muscle cells. Nephrol Dial Transplant 1999; 14:597-603.
24. 24 Koide M, Kawahara Y, Nakayama I, Tsuda T, Yokoyama M. Cyclic AMP elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. J Biol Chem 1993; 268: 24959-24966.
25. 25 Iimura O, Kusano E, Amemiya M, Muto S, Ikeda U, Shimada K, et al. Dipyridamole enhances interleukin-1β-stimulated nitric oxide production by cultured rat vascular smooth muscle cells. Eur J Pharmacol 1996; 296:319-326.
26. 26 Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and 15N niterate in bilogical fluids. Anal Biochem 1982; 126:131-138.
27. 27 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidine thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-159.
28. 28 Yasuda I, Kishimoto A, Tanaka S, Tominaga M, Sakurai A. Nishizuka Y. A synthetic peptide substrate for selective assay of protein kinase C. Biophys Res Commun 1990; 166:1220-1227.
29. 29 Masuda S, Nagao M, Takahara K, Konishi Y, Gallyas F, Tabira T, et al. Functional erythropoietin receptor of the cells with neural characteristics. J Biol Chem 1993; 268:11208-11216.
30. 30 Kuromachi S, Ikawa Y, Todokoro K. Characterization of murine erythropoietin receptor genes. J Mol Biol 1990; 216:567-575.
31. 31 Griendling KK, Tsuda T, Alexander RW. Endothelin stimulates diacylglycerol accumulation and activates protein kinase C in cultured vascular smooth muscle cells. J Biol Chem 1989; 264:8237-8240.
32. 32 Neusser M, Tepel M, Zidek W. Erythropoietin increases cytosolic free calcium concentration in vascular smooth muscle cells. Cardiovasc Res 1993; 27:1233-1236.
33. 33 Heidenreich S, Rahn KH, Zideck W. Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels. Kidney Int 1991; 39:259-265.
34. 34 Vogel V, Kramer HJ, Bäcker A, Meyer-Lehnert H, Jelkmann W, Fandrey J. Effects of erythropoietin on endothelin-1 synthesis and the cellular calcium messenger system in vascular endothelial cells. Am J Hypertens 1997; 10:289-296.
35. 35 Gogusev J, Zhu DL, Herembert T, Ammarguellat F, Marche P, Drueke T. Effect of erythropoietin on DNA synthesis, proto-oncogene expression and phospholipase C activity in rat vascular smooth muscle cells. Biochem Biophys Res Commun 1994; 199:977-983.
36. 36 Nahorski SR, Wilcox RA, Mackrill JJ, Challiss RA. Phosphoinositide-derived second messengers and the regulation of Ca2+ in vascular smooth muscle. J Hypertens 1994; 12 (suppl 10):S133-S143.
37. 37 Nakayama I, Kawahara Y, Tsuda T, Okuda M, Yokoyama M. Angiotensin II inhibits cytokine-stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells. J Biol Chem 1994; 269:11628-11633.
38. 38 Kusano E, Tian S, Umino T, Tetsuka T, Ando Y, Asano Y. Arginine vasopressin via V1 receptor inhibits IL-1b stimulated nitric oxide and cGMP production in cultured rat vascular smooth muscle cells. J Hypertens 1997; 15:627-632.
39. 39 Yamamoto K, Ikeda U, Okada K, Saito T, Shimada K. Arginine vasopressin inhibits nitric oxide synthesis in cytokine stimulated vascular smooth muscle cells. Hypertens Res 1997; 20:209-216.
40. 40 Geng Y, Wu Q, Hansson GK. Protein kinase C activation inhibits cytokine-induced nitric oxide snthesis in vascular smooth muscle cells. Biochem Biophys Acta 1994; 1223:125-132.
41. 41 Pollman MJ, Yamada T, Horiuchi M, Gibbons GH. Vasoactive substance regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II. Circ Res 1996; 79:748-756.
42. 42 Fukuo K, Hata S, Suhara T, Nakahashi T, Shinto Y, Tsujimoto Y, et al. Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle cells. Hypertension 1996, 27:823-826.
43. 43 Kawagishi T, Nishizawa Y, Konishi T, Kawasaki K, Emoto M, Shoji T, et al. High-resolution ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int 1995; 48:820-826.
44. 44 Ibels LS, Alfrey AC, Hufer WE, Craswell PW, Anderson JT, Weil R. Arterial calcification and pathology in uremic patients undergoing dialysis. Am J Med 1979; 66:790-796.
45. 45 Beasley D, Brenner BM. Role of nitric oxide in hemodialysis hypotension. Kidney Int 1992; 42 (suppl 38):S96-S100.
46. 46 Madore F, Prud'homme L, Austin J, Blaise G, Francoeur M, Léveillé M, et al. Impact of nitric oxide on blood pressure in hemodialysis patients. Am J Kidney Dis 1997; 30:665-671.